When combined with immune checkpoint inhibitors such as anti-PD-1/PD-L1 and anti-CTLA-4 mAbs, curcumin presented excellent antitumor effects by downregulating cytokine secretion, inhibiting NF-κB pathway and promoting the infiltration of anti-tumor T cells 101. This evidence concerns the gene CD274 and neoplasm.